Clofedanol
Systematic (IUPAC) name | |
---|---|
1-(2-chlorophenyl)-3-dimethylamino- 1-phenyl-propan-1-ol | |
Clinical data | |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
Legal status | ? |
Routes | Oral |
Identifiers | |
CAS number | 791-35-5 |
ATC code | R05DB10 |
PubChem | CID 2795 |
DrugBank | DB04837 |
ChemSpider | 2693 |
UNII | 42C50P12AP |
KEGG | D07721 |
ChEMBL | CHEMBL1201313 |
Chemical data | |
Formula | C17H20ClNO |
Mol. mass | 289.8 g/mol |
SMILES
| |
| |
(what is this?) (verify) | |
Clofedanol (INN) or chlophedianol (BAN) is a centrally-acting cough suppressant used in the treatment of dry cough. Clofedanol has local anesthetic and antihistamine properties, and may have anticholinergic effects at high doses.[1] It is marketed in Canada under the trade name Ulone, but is not available currently in the United States. In August 2009, Centrix Pharmaceutical announced the launch of a cough syrup containing a mixture of clophedianol and pseudoephedrine, marketed under the brand name Clofera. It has a release to market date in the beginning of the fourth quarter 2009.[2] Chlophedianol was approved for OTC status in 1987 by the FDA OTC monograph process[3] and its safety and efficacy data are limited.
References
- ↑ (French) "Clofedanol". BIAM. 1998-07-24. Retrieved 2007-04-15.
- ↑ "Centrix Pharmaceutical Announces Clofera(TM), a Unique Antitussive and Nasal Decongestant for the Temporary Relief of Cough and Nasal Congestion". Cenrx.com. Retrieved 2009-09-27.
- ↑ "Department of Health and Human Services. Food and Drug Administration. 21 CFR Parts 310, 341, and 369. Docket No. 76N-052T. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the0counter human use; final monograph for OTC antitussive drug products. Federal Register 1987;52(155):30042-57". FDA.gov. 1987-08-12.
|